If it feels like shares of technology giant and AI powerhouse Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) have underperformed of late, you're not imagining things. They have.
ECB strongly expected lift interest rates 25 basis points to 2.5% at its policy meeting ThursdayChristine Lagarde's term as president of the ECB expires next October.Futures markets are pricing in a ...
Josh Silverman, Executive Chair of the Board, sold 13,367 shares of Etsy, Inc. (NYSE:ETSY) in a transaction disclosed in a SEC Form 4 filing.Transaction summaryTransaction value based on SEC Form 4 ...
It would be an understatement to say that Wall Street is bullish on Nvidia (NASDAQ: NVDA).The artificial intelligence (AI) chip manufacturer announced its second-quarter results on Aug. 26, and they ...
Investors love to check automakers' quarterly (or otherwise) delivery figures, especially when it comes to young electric vehicle (EV) makers that are surviving amid low volume and scale.
A couple of years ago, when artificial intelligence (AI) chatbots were in their early stages of development, Berkshire Hathaway (NYSE:BRKA)(NYSE:BRKB) wasn't jumping aboard the craze.
Valero Energy (VLO) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...
CEO Jensen Huang called the sharp technology sector sell-off that occurred in early June a buying opportunity. Speaking to reporters in Seoul that day, Huang said the artificial intelligence (AI) ...
There are few things income investors love more than a high-yield dividend.What if you could combine this with a stock that has outpaced the broader market, at times obliterating a top equity index?
IonQ (NYSE: IONQ) is getting a chance to prove that its expansion beyond quantum computing can become a real business.
GSK plc's GSK Specialty Medicines business has become the company's most important growth engine. The segment includes HIV, Respiratory, Immunology & Inflammation (RI&I) and Oncology, and its ...
— We have everything you need: full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock ...